Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Psychiatry

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Cortical functional activity in patients with generalized anxiety disorder

  • Yiming Wang1Email author,
  • Fangxian Chai1,
  • Hongming Zhang2,
  • Xingde Liu3Email author,
  • Pingxia Xie1,
  • Lei Zheng1,
  • Lixia Yang1,
  • Lingjiang Li4 and
  • Deyu Fang5
Contributed equally
BMC PsychiatryBMC series – open, inclusive and trusted201616:217

https://doi.org/10.1186/s12888-016-0917-3

Received: 15 February 2016

Accepted: 8 June 2016

Published: 7 July 2016

Abstract

Background

The neurological correlates of Generalised Anxiety Disorder (GAD) are not well known, however there is evidence of cortical dysregulation in patients with GAD. The aim of the study was to examine cortical functional activity in different cerebral regions in patients with GAD using electroencephalogram (EEG) nonlinear analysis to evaluate its contribution of anxiety severity.

Methods

The cohorts consisted of 64 patients diagnosed with GAD as classified by the Structured Clinical Interview for the Diagnostic and Statistical Manual of the American Psychiatric Association-IV-TR. Anxiety severity was assessed using the Hamilton Rating Scale for Anxiety (HAMA) severity score, with 7 ≤ scores ≤ 17 indicating mild anxiety as A group (n = 31) and 18 and above indicating moderate-severe anxiety as B group (n = 33). Participants with clinical levels of depression symptoms were excluded. A healthy control group comprising 30 participants was matched for age and gender. Closed eyes EEGs were conducted, and between-group differences on non-linear parameter Correlation Dimension (D2) were analyzed. The association of D2 value with HAMA scores was analyzed using multiple linear stepwise regression.

Results

Compared with the control group, D2 values were increased in anxiety groups (P < .05). For those with mild anxiety, this difference occurred in the left prefrontal regions (P < .05). For those with moderate-severe anxiety, significantly greater D2 values were observed in all of the cerebral regions, especially in the left cerebral regions and right temporal lobe (P < .01). When compared with those with mild anxiety, D2 values were significantly greater for those with moderate-severe anxiety in the right temporal lobe and all left cerebral regions except for left occipital lobe (P < .05). A positive correlation was observed between D2 values and moderate-severe anxiety HAMA scores.

Conclusions

The increased D2 values were found in the majority of cerebral regions in GAD patients, especially in the left cerebral regions and the right temporal lobe. The increased GAD severity positively correlates to the D2 values in a larger number of cerebral regions. This analysis method can potentially be used as a complementary tool to examine dysfunctional cortical activity in GAD.

Keywords

PsychiatryGeneralized anxiety disorderEEG nonlinear analysisCorrelation dimensionCortical functional activity

Background

General anxiety disorder (GAD) is a common and chronic anxiety disorder characterized by persistent worry [1]. While advancements have been made in our understanding of the psycho-physiology of GAD in recent years, the neurological correlates of GAD remain poorly understood. Previous studies using functional magnetic resonance imaging (fMRI) have demonstrated that the anterior cingulate and the medial prefrontal regions were activated in GAD patients [2], suggesting some cortical activity was dysfunctional in GAD patients [3]. Other fMRI studies found that both the ventral prefrontal cortex (vPFC) and amygdala region are correlation with social anxiety disorder [4]. What remains unclear however, is whether other cerebral regions are also differentially engaged in people with anxiety when compared to those without, and whether there is a relationship between severity of anxiety disorder and cerebral region functional activity.

EEG is an important noninvasive method to explore cortical neuronal activity by placing electrodes on the scalp, including waveform investigations and power spectra analysis [58]. Molina et al [9] reported that patients with obsessive compulsive disorder (OCD) have increased beta and theta power in the EEG and perfusion in frontal regions. However, the complex dynamic changes in brain cannot be discriminated using the technique [10]. Furthermore, EEG with nonlinear features and complexity parameter, for example correlation dimension (D2), approximate entropy (ApEn), fractal dimension (FD), have been suggested as more suitable techniques for analyzing cerebral dynamic activity. The linear EEG is sufficient and well used for the clinical symptom classification of brain diseases as well as brain electronic signal alterations under different stress conditions, but the non-linear EEG analysis in fractal dimension [11] provides a better analysis of quantification to identify EEG changes in response to special stimulating conditions such as the GAD. D2 is known as one of nonlinear parameter for studying dynamic behaviors.

Another study using quantitative electroencephalography (qEEG) in patients with anxiety have shown decreased alpha, beta and theta activity, especially in cerebral middle and central regions [12], and basal instability in cortical arousal has also been found [13]. Nonlinear EEG analysis is a new research tool that is being utilized in the study of different physiologic conditions, for example sleep and dementia [14, 15]. The D2 in the EEGs nonlinear analysis, is defined as an index of complexity of information processing representing the cerebral cortical dynamics and behavior. D2 has been used in experimental and clinical settings in studying schizophrenia [16]. Decreased D2 values have been detected in patients with seizure epilepsy [17], Alzheimer’s disease [18], schizophrenia [19], and depression [20].

The aim of this study was to use EEG nonlinear dynamics analysis to compare functional changes of the cerebral cortex in patients with or without GAD and to evaluate the impact of the severity of anxiety on cortical functional activity.

Methods

Subjects

The study sample consisted of 64 patients with GAD (30 men and 34 women, aged 20–63 years) recruited from the department of psychiatry at the Affiliated Hospital of Guiyang Medical University, from June 2010 to January 2011. All consenting participants met diagnostic criteria for GAD according to the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders-IV-TR. (DSM-IV) and scored ≥7 on the Hamilton Anxiety Rating Scale (HAMA) [21]. Participants with clinical levels of depression symptoms (defined by a score of ≥ 53 on the Zung Self-Rating Depression Scale (SDS) [22]) were excluded. Participants were categorised according to their HAMA scores as having either “mild anxiety” (7 ≤ scores ≤ 17) or “moderate-severe anxiety” (HAMA ≥ 18) for evaluating the impact of the severity of anxiety on cortical functional activity. Healthy control participants (n = 30) who did not meet the diagnostic criteria for GAD according to the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders-IV-TR (DSM-IV) and scored ≤ 6 on the Hamilton Anxiety Rating Scale (HAMA) were recruited. Diagnostic interviews were conducted by two psychiatrists. Exclusion criteria for all participants included secondary somatic diseases (hyperthyroidism, hypertension and coronary heart disease).

Selective serotonin-reuptake inhibitors (SSRIs) were routinely used to treat patients with anxiety, concomitant short term use of benzodiazepines was allowed (alprazolam (Xanax), 0.8 mg/day, bid for 2 weeks Yabao pharmaceutical Taiyuan Pharmaceutical Co., Ltd.).

Assessment

The severity of anxiety

Severity of anxiety symptoms was assessed using the HAMA. This is a 14 item clinician rated scale, with each item rated 0-4 where a higher score indicates more severe symptoms [23], with a total anxiety score range from 0 to 56, score ≤ 17 indicates mild severity, where ≥ 18 shows mild to moderate, and 25–30 indicates moderate-severe.

EEG nonlinear analysis

EEG was conducted in a quiet room with soft lighting. EEG electrodes were placed in accordance with international standards for leads 10–20, specifically left and right forehead (FP1, FP2); left and right frontal (F3, F4); left and right central (C3, C4); left and right parietal (P3, P4); left and right occipital (O1, O2); left and right anterior temporal (F7, F8); left and right temporal (T3, T4); left and right posterior temporal (T5, T6). The left and right earlobe (A1, A2) were used as reference sites. The data was acquired and analyzed using 16-channel EEG (Wireless Digital EEG, ZN16E, Chengdu, China), the EEG with international 10–20 system was used to obtain EEGs in the subjects [24].

In resting state, EEG signals were recorded from each participant, who was asked to close eyes and keep on a relax condition without movement during the 5 min data collection period. EEG data in each interval (180 s) were selected from the 5 min collection period and divided into 6 segments with 30s each for nonlinear processing. Any artifact sources caused by eye-blink and movement in EEG recording were eliminated by the component analysis system based on their different frequencies and patterns as this analysis system is able to recognize the unique patterns of electronic signaling caused by the eye blink.

The D2 value was calculated using a nonlinear software packet embedded in the 16-channel Wireless Digital EEG system. D2 is an index of the variation within a selected time series, reflecting the complexity of a non-linear system. Nonlinear EEG analyzes the brain activity using nonlinear dynamic mathematics and chaos theory, which allows us to monitor the dynamics and complicated electronic activity [25]. Natural and biological phenomena often displays features of nonlinear dynamics, particularly respond to perturbing stimuli or initial conditions [26].

The D2 values are shown as the average of data collected from all the brain regions of each patients as indicated in Table 2. The differences among controls and patients with anxiety of mild symptoms, or moderate-severe symptoms were statistically evaluated based on the method of Lacasa [27].

Statistics analyses

Data analysis was carried out using SPSS 19.0 software. The results were described using Median ± Quartile (M ± Q). The Rank Sum Test was carried out among the three groups (control, mild anxiety, moderate-severe anxiety). P < 0.05 was considered as statistical significant. The final regression model was Ŷ = 2.7985-0.417X1 + 0.533 X2 (Ŷ: estimates the value of the correlation dimension D2, X1: the patient’s age, X2: HAMA score of patients). The association between D2 and HAMA scores was analyzed between moderate-severe anxiety (B group) and control groups using multiple linear stepwise regression, significance was set at α = .05.

Results

Demographic characteristics

The key characteristics of the patient cohorts are displayed in Table 1. No significant differences were found between the control, GAD A and B groups in the demographic variables (age, sex) between the control and GAD A and B groups. Their smoking status and blood pressure ratings of patients and control groups were indicated, the percentages of smoking populations and average blood pressure in each group are comparable (Table 1).
Table 1

Demographic data between the control and GAD groups (Mean ± SEM)

Items

Control (n = 30)

A (n = 31)

B (n = 33)

Ages (years)

45.41 ± 6.33

46.41 ± 7.56

46.37 ± 6.42

(Ranges)

20–65

20–63

21–58

Gender (male/female) (n)

14/16 (47 %/53 %)

15/16 (48 %/52 %)

15/18 (46 %/54 %)

Resting SBP (mm Hg)

120 ± 20

125 ± 22

130 ± 20

Resting DBP (mm Hg)

70 ± 12

72 ± 10

76 ± 10

Smokers/non-smokers (n)

15/15 (50 %/50 %)

16/15 (52 %/48 %)

18/15 (55 %/45 %)

No significant differences in the demographic variables (age, sex, blood pressure, smoking) between the control and GAD A and B groups, were observed

SBP systolic blood pressure, DBP diastolic blood pressure, GAD Generalised Anxiety Disorder, Group A: mild symptoms of anxiety; Group B: moderate-severe symptoms of anxiety

The comparison of Correlation Dimension between the groups

Compared with the control group, D2 values were increased in anxiety groups (P < .05). For those with mild anxiety, this difference occurred only in the left prefrontal regions (P < .05). For those with moderate-severe anxiety, significantly greater D2 values were observed in all of the cerebral regions, especially in the left cerebral regions and right temporal lobe (P < .01). When compared with those with mild anxiety, D2 values were significantly greater for those with moderate-severe anxiety in the right temporal lobe and all left cerebral regions except for left occipital lobe (P < .05) (Tables 2 and 3).
Table 2

The comparison of Correlation Dimension in different groups (M ± Q)

Group

n

Left prefrontal (FP1-A1)

Right forehead (FP2-A2)

Left frontal (F3-A1)

Right frontal (F4-A2)

Left central (C3-A1)

Right central (C4-A2)

Left parietal (P3-A1)

Right parietal (P4-A2)

Control

30

3.57 ± 0.48

3.53 ± 0.58

3.64 ± 0.36

3.61 ± 0.43

3.66 ± 0.44

3.66 ± 0.51

3.65 ± 0.34

3.59 ± 0.49

A

31

3.36 ± 0.24*

3.41 ± 0.46

3.52 ± 0.35

3.58 ± 0.37

3.55 ± 0.36

3.66 ± 0.33

3.59 ± 0.39

3.58 ± 0.37

B

33

3.66 ± 0.69▲▲

3.52 ± 0.59

3.95 ± 0.33**▲▲

3.81 ± 0.35▲▲

3.94 ± 0.33**▲▲

3.85 ± 0.27▲▲

3.97 ± 0.27**▲▲

3.80 ± 0.41▲▲

P

 

0.000

0.016

0.000

0.004

0.000

0.003

0.000

0.006

Compared with control group, *P < .05, **P < .01;compared with group A, P < .05,▲▲P < .01

Group A: mild symptoms of anxiety; Group B: moderate to severe symptoms of anxiety

Table 3

The comparison of Correlation Dimension in different groups (M ± Q)

Group

n

Left occipital (O1-A1)

Right occipital (O2-A2)

Left anterior temporal (F7-A1)

Right anterior temporal (F8-A2)

Left temporal (T3-A1)

Right temporal (T4-A2)

Left posterior temporal (T5-A1)

Right posterior temporal (T6-A2)

Control

30

3.62 ± 0.59

3.69 ± 0.57

3.63 ± 0.54

3.71 ± 0.56

3.91 ± 0.69

3.86 ± 0.50

3.78 ± 0.36

3.60 ± 0.59

A

31

3.45 ± 0.61

3.42 ± 0.47*

3.43 ± 0.58

3.70 ± 0.46

3.66 ± 0.72

3.65 ± 0.71

3.61 ± 0.54

3.55 ± 0.54

B

33

3.99 ± 0.23**▲▲

3.81 ± 0.51▲▲

4.05 ± 0.82**▲▲

3.89 ± 0.36▲▲

4.29 ± 0.49**▲▲

4.01 ± 0.51▲▲

4.14 ± 0.51**▲▲

3.81 ± 0.32▲▲

P

 

0.000

0.000

0.000

0.004

0.000

0.005

0.000

0.006

Compared with control group, *P < .05, **P < .01;compared with group A, P < .05,▲▲P < .01

Group A: mild symptoms of anxiety; Group B: moderate to severe symptoms of anxiety

Association between D2 value and HAMA scores

Multiple linear stepwise regression analysis revealed that, for the GAD B group, D2 values and HAMA scores were positively correlated (r > .63, P < .05) in the left prefrontal, frontal, central, parietal occipital, anterior temporal, temporal, posterior temporal regions (Fig. 1).
Fig. 1

Correlation Dimension correlation with HAMA score. The Correlation Dimension values and moderate-severe anxiety HAMA scores were positively correlated (r s  > .63, P < .05) in the left prefrontal, frontal, central, parietal occipital, anterior temporal, temporal, posterior temporal regions (a-h)

Discussion

This study found that individuals with GAD have dysfunctional cortical activity in the majority of cerebral regions, especially in the left cerebral regions and right temporal lobe. Moreover, more severe anxiety was associated with involvement of a larger number of cerebral regions. Specifically, we demonstrated increased values of D2 in frontal temporal regions in GAD patients, suggestive of temporal lobe cortical dysfunction. These association is unlikely affected by their smoking status and blood pressure because the percentages of smoking populations and average blood pressure in each group are comparable. Glosser et al. found that patients with anterior temporal lobectomy often develop mood disorders and the severity of psychiatric symptoms peak in the 6 months after surgery [28]. It is possible that dysfunction of the frontal and temporal regions can result in emotional changes [29], and the results of an fMRI study on patients with GAD also revealed dysfunction in the bilateral superior temporal gyrus and dorsal prefrontal cortex [30]. However, given the cross-sectional nature of these data and the multiple comparisons used, identifying the true direction of this relationship requires further investigation.

In the current report, we found increased D2 values in patients with greater GAD severity, lateralized to the left hemisphere (the dominant hemisphere as all participants were right-handed). To our knowledge, this is the first study to demonstrate significant differences in cerebral hemisphere in left and right laterality, however the machanism is not clear. Kalisch et al. [31] used the magnetic resonance imaging at 7 T to measure hippocampal volumes in a rat model of extremes in trait anxiety (experiment 1) and in a Wistar population with normal anxiety-related behavior (experiment 2). While experiment 2 yielded a strong evidence for a negative relationship which was specific for trait anxiety, results from experiment 1 globally supported the hypothesis of a positive relationship between hippocampus volume and trait anxiety. Therefore, as what the authors stated, the relationship between hippocampal volume and anxiety may be more complex than expected, thus we speculate that this increase in D2 value is associated to the cortical dysfunctional activity in these patients.

We agree with the reviewer that the temporal and hippocampal regions are not the same. It has been reported [32] that the volume in the whole-brain gray matter, not only in the hippocampal region, but also including superior temporal gyrus and midbrain, is reduced in patients with GAD. It has also been shown [33] that the reduced white matter (WM) volume were associated with dysfunctional cognitive and emotional in GAD, WM volume is correlation with symptom severity. Implying that dysfunctional activities can occur both in cerebral cortex and hippocampal regions correlation with clinical characteristics. However, it would be technically challenging to detect the hippocampal dysfunctional activation by EEG in human. Although the use of Nonlinear EEG to analyze generalized anxiety disorder has not been reported, this analysis method is suggested in further research the ralationship between cerebral cortex volume and generalized anxiety disorder, and as a complementary tool to detect dysfunctional cortical activity in GAD.

A strength of this study was the use of neuroimaging to investigate cortical dysfunctional activity. The nonlinear analysis method was sufficiently sensitive to detect differences in cortical activity between patients with different levels of anxiety, a finding that may have implications for the clinical diagnosis of GAD. Currently, a diagnosis of GAD relies on clinical judgment, using information gathered via symptom assessment and responses to standardized scales. However, a disadvantage of clinical judgment is subjectivity; diagnosis will be influenced by clinical training, experience and other subjective factors and may differ amongst clinicians. This technique, however, remains the gold standard for psychiatric diagnostic assessment.

Neuroimaging techniques may impact upon the nosology of mental disorders in the future and have the capacity to influence psychiatric practice by potentially improving clinical treatment [34]. Indeed, these have been valuable in other areas of psychiatry, for example, in depressed populations, via fMRI [35], positron emission tomography (PET) [36] and single-photon emission computed tomography (SPECT) [37, 38]. These differing neuroimaging methodologies, fMRI, PET, SPECT and EEGs nonlinear analysis offer complimentary insights into neurobiology, and each have their strengths and weaknesses. fMRI and PET techniques can not directly detect neuronal activity, neither can EEG. Linear analysis methods have limits in stability and sensitivity in detecting complicated cortex function as EEG signals originate in a highly nonlinear system [39, 40]. Further, nonlinear dynamics analysis can provide information about the neural network [41] and track the changes cerebral functional activity [42, 43] which cannot be detected with linear analysis. This technique has also shown to be more sensitive than linear analysis in detecting subtle aspects of emotional processing. Indeed, EEG nonlinear analysis has been widely used in other populations (epilepsy [44, 45], schizophrenia [46], dementia [47]), to monitor the depth of anesthesia [4850], and is effective in evaluating patients being treated for acute carbon monoxide poisoning [51]. As the electrical activity of the human brain self-organizing nonlinear dynamic systems is complex, and the neural circuits are extensive and full of synaptic connections [52]. The non-linear method in the current study has a great potential in delineating the complexity of EEG in patients with different psychological disorders.

However, we acknowledge that there are certain limitations when interpreting these data. The sample size was not extensive, limiting ability to further analysis the relationship between anxiety disorder severity and EEG non-linear parameters. However, given the cross-sectional nature of these data and the multiple comparisons used, identifying the true direction of this relationship requires further investigation.”

Conclusions

Patients with GAD demonstrate dysfunctional cortical activity in the majority of cerebral regions, the increased D2 values were found in the majority of cerebral regions in GAD patients, especially in all the left cerebral regions and right temporal lobe, GAD severity positively correlate with increased D2 values in a larger number of cerebral regions. Our study demonstrates that EEG dynamic non-linear analysis is appropriate for the investigation of the neurological correlates of GAD, and holds potential for the further evaluation of cortical dysfunctional activity in patients with varying levels of GAD severity and assessment of treatment effects, this analysis method is also suggested as a complementary tool to detect dysfunctional cortical activity in GAD.

Abbreviations

D2, Correlation Dimension; DBP, diastolic bood pressure; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders-IV-TR; EEG, electroencephalogram; fMRI: functional magnetic resonance imaging; GAD, Generalised Anxiety Disorder; HAMA, Hamilton Rating Scale for Anxiety; PET, positron emission tomography; SBP, systolic blood pressure; SDS, Zung Self-Rating Depression Scale; SPECT, single-photon emission computed tomography; vPFC, ventral prefrontal cortex

Declarations

Acknowledgements

This study was supported by National Natural Science Foundation of China, Project Grant: [2015] 81560235, National Clinical Research Center for Mental Health Disorders (2015BAI13B02). Clinical key subjects in Guizhou Province (2014). All authors had a role in either the design of study, in the collection of material, analysis and interpretation of data, in the writing of the paper; and in the decision to submit the paper for publication.

Availability of data and materials

The datasets supporting the conclusions of this article are included within the article.

Authors’ contributions

YW and XL participated in the design of the study and performed the statistical analysis, FC, PX, LZ, LY carried out the studies tests, DF, LL and HZ participated in coordination and drafting of the manuscript. All authors participated in data interpretation, drafting of the manuscript and have read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

The study involved in the paticipatation of patients and healthy volenteers was approved by the Affiliated Hospital Ethics Committee of Guizhou Medical University (NO 10/2010).

All participants gave their written informed consent to participate. The procedures followed were in accordance with the revised Declaration of Helsinki of 1964 [53].

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Psychiatry, Affiliated Hospital of Guizhou Medical University
(2)
Department of Cardiolog, The General Hospital of Jinan Military Region
(3)
Department of Cardiolog, Affiliated Hospital of Guizhou Medical University
(4)
The second Xiangya Hospital, Central South University
(5)
Department of Pathology, Northwestern University Feinberg School of Medicine

References

  1. Wu WY, Wang G, Susan GB, Durisala D, ANG QQ. Duloxetine versus placebo in the treatment of patients with generalized anxiety disorder in China. Chin Med J. 2011;124:3260–8.PubMedGoogle Scholar
  2. Paulesu E, Sambugaro E, Torti T, Danelli L, Ferri F, Scialfa G, Sberna M, Ruggiero GM, Bottini G, Sassaroli S. Neural correlates of worry in generalized anxiety disorder and in normal controls: a functional MRI study. Psychol Med. 2010;40:117–24.View ArticlePubMedGoogle Scholar
  3. Jetty PV, Charney DS, Goddard AW. Neurobiology of generalized anxiety disorder. Psychiatr Clin North A. 2001;24:75–97.View ArticleGoogle Scholar
  4. Guyer AE, Nelson EE. Amygdala and ventrolateral prefrontal cortex function during anticipated peer evaluation in pediatric social anxiety. Arch Gen Psychiatry. 2008;65:1303–12.View ArticlePubMedPubMed CentralGoogle Scholar
  5. Reid SA, Duke LM, Allen JJ. Resting frontal electroencephalographic asymmetry in depression: inconsistencies suggest the need to identify mediating factors. Psychophysiology. 1998;35:389–404.View ArticlePubMedGoogle Scholar
  6. Allen JJ, Urry HL, Hitt SK, Coan JA. The stability of resting frontal elec-troencephalo graphic asymmetry in depression. Psychophysiology. 2004;41:269–80.View ArticlePubMedGoogle Scholar
  7. Sumich A, Harris A, Flynn G, Whitford T, Tunstall N, Kumari V, Brammer M, Gordon E, Williams LM. Event-related potential correlates of depression, insight and negative symptoms in males with recent-onset psychosis. Clin Neurophysiol. 2006;117:1715–27.View ArticlePubMedGoogle Scholar
  8. Bares M, Brunovsky M, Kopecek M, Stopkova P, Novak T, Kozeny J, Höschl C. Changes in QEEG prefrontal cordance as a predictor of response to anti-depressants in patients with treatment resistant depressive disorder: a pilot study. J Psychiatr Res. 2007;41:319–25.View ArticlePubMedGoogle Scholar
  9. Molina V, Montz R, Pérez-Castejón MJ, Martin-Loeches M, Carreras JL, Calcedo A, Rubia FJ. Cerebral perfusion, electrical activity and effects of serotonergic treatment in obsessive-compulsive disorder. A preliminary study. Neuropsychobiology. 1995;32:139–48.View ArticlePubMedGoogle Scholar
  10. Acharya UR, Sudarshan VK, Adeli H, Santhosh J, Koh JE, Adeli A. Computer-aided diagnosis of depression using EEG signals. Eur Neurol. 2015;73:329–36.View ArticlePubMedGoogle Scholar
  11. Cusenza M, Accardo A, Monti F, Bramanti P. Linear and non-linear effects of gradient artifact filtering methods in simultaneous EEG-FMRI - biomed 2010. Biomed Sci Instrum. 2010;46:374–9.PubMedGoogle Scholar
  12. Demerdzieva A. Eeg Characteristics of Generalized Anxiety Disorder in Childhood. Acta Informatica Medica. 2011;19:9–15.Google Scholar
  13. Clark CR, Galletly CA, Ash DJ, Moores KA, Penrose RA, McFarlane AC. Evidence-based medicine evaluation of electrophysiological studies of the anxiety disorders. Clin EEG and neurosci. 2009;40:84–112.View ArticleGoogle Scholar
  14. Pradhan N, Dutt DN. A nonlinear perspective in understanding the neurodynamics of EEG. Comput Biol Med. 1993;23:425–42.View ArticlePubMedGoogle Scholar
  15. Babloyantz A, Salazar JM, Nicolis C. Evidence of chaotic dynamics of brain activity during the sleep cycle. Phys Lett A. 1985;111:152–6.View ArticleGoogle Scholar
  16. Carlino E, Sigaudo M, Pollo A, Benedetti F, Mongini T, Castagna F, Vighetti S, Rocca P. Nonlinear analysis of electroencephalogram at rest and during cognitive tasks in patients with schizophrenia. J Psychiatry Neurosc. 2012;37:259–66.View ArticleGoogle Scholar
  17. Lehnertz K, Elger C. Can epileptic seizures be predicted? Evidence from non-linear time series analysis of brain electrical activity. Phys Rev Lett. 1998;80:5019–22.View ArticleGoogle Scholar
  18. Jeong J, Chae JH, Kim SY, Han SH. Non-linear dynamical analysis of the EEG in patients with Alzheimer’s disease and vascular dementia. J Clin Neurophysiol. 2001;112:827–35.View ArticleGoogle Scholar
  19. Kirsch P, Besthorn C, Klein S, Rindfleisch J, Olbrich R. The dimensional complexity of the EEG during cognitive tasks reflects the impaired information processing in schizophrenic patients. Int J Psychophysiol. 2000;36:237–46.View ArticlePubMedGoogle Scholar
  20. Hosseinfard B, Moradi MH, Rostami R. Classifying depression patients and normal subjects using machine learning techniques and nonlinear features from EEG signal. Comput Methods Programs Biomed. 2013;109:339–45.View ArticleGoogle Scholar
  21. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50–5.View ArticlePubMedGoogle Scholar
  22. Zung, William WK, Richards CB, Short MJ. Self-rating depression scale in an outpatient clinic: further validation of the SDS. Arch Gen Psy. 1965;13:508–15.View ArticleGoogle Scholar
  23. Maier W, Buller R, Philipp M, Heuser I. The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. J Affect Disord. 1988;14:61–8.View ArticlePubMedGoogle Scholar
  24. Wang J, Wu D, Chen Y, Yuan Y, Zhang M. Effects of transcranial direct current stimulation on language improvement and cortical activation in nonfluent variant primary progressive aphasia. Neurosci Lett. 2013;549:29–33.View ArticlePubMedGoogle Scholar
  25. Skinner JE, Carpeggiani C, Landisman CE, Fulton KW. Correlation dimension of heartbeat intervals is reduced in conscious pigs by myocardial ischemia. Circ Res. 1991;68:966–76.View ArticlePubMedGoogle Scholar
  26. Strogatz SH. Nonlinear Dynamics and Chaos: With Applications to Physics, Biology, Chemistry and Engineering (Studies in nonlinearity) (Paperback). 1994. p. 1.Google Scholar
  27. Lacasa L, Gómez-Gardeñes J. Analytical estimation of the correlation dimension of integer lattices. Chaos. 2014;24:043101.View ArticlePubMedGoogle Scholar
  28. Glosser G, Zwil AS, Glosser DS, O’Connor MJ, Sperling MR. Psychiatric aspects of temporal lobe epilepsy before and after anterior temporal lobectom. J Neurol Neurosur Ps. 2000;68:53–8.View ArticleGoogle Scholar
  29. Donald TS, Gow CA, Ross HC. “No longer gage”: Frontal lobe dysfunction and emotional changes. J Consul Clin Psychol. 1992;60:349–59.View ArticleGoogle Scholar
  30. Zhao XH, Wang PJ, Li CB, Wang JH, Yang ZY, Hu ZH, Wu WY. Prefrontal and superior temporal lobe hyperactivity as a biological substrate of generalized anxiety disorders. Nat Med J Chin. 2006;86:955–60.Google Scholar
  31. Kalisch R, Schubert M, Jacob W, Kessler MS, Hemauer R, Wigger A, Landgraf R, Auer DP. Anxiety and hippocampus volume in the rat. Neuropsychopharmacology. 2006;31:925–32.View ArticlePubMedGoogle Scholar
  32. Moon CM, Kim GW, Jeong GW. Whole-brain gray matter volume abnormalities in patients with generalized anxiety disorder: voxel-based morphometry. Neuroreport. 2014;25:184–9.View ArticlePubMedGoogle Scholar
  33. Moon CM, Jeong GW. Alterations in white matter volume and its correlation with clinical characteristics in patients with generalizedanxiety disorder. Neuroradiology. 2015;57:1127–34.View ArticlePubMedGoogle Scholar
  34. Malhi GS, Lagopoulos J. Making sense of neuroimaging in psychiatry. Acta Psychiatr Scand. 2007;1:1–18.View ArticleGoogle Scholar
  35. Guo WB, Liu F, Xue ZM, Yu Y, Ma CQ, Tan CL, Sun XL, Chen JD, Liu ZN, Xiao CQ, Chen HF, Zhao JP. Abnormal neural activities in first-episode, treatment-naïve, short-illness-duration, and treatment-response patients with major depressive disorder: A resting-state fMRI study. J Affect Disord. 2011;135:326–31.View ArticlePubMedGoogle Scholar
  36. Post RM, DeLisi LE, Holcomb HH, Uhde TW, Cohen R, Buchsbaum MS. Glucose utilization in the temporal cortex of affectively ill patients: positron emission tomography. Biol Psychiat. 1987;22:545–53.View ArticlePubMedGoogle Scholar
  37. Davies J, Lloyd KR, Jones IK, Barnes A, Pilowsky LS. Changes in regional cerebral blood flow With Venlafaxine in the Treatment of Major Depression. Am J Psychiat. 2003;160:374–6.View ArticlePubMedGoogle Scholar
  38. Milo TJ, Kaufman GE, Barnes WE, Konopka LM, Crayton JW, Ringelstein JG, Shirazi PH. Changes in RCBF After Electroconvulsive Therapy for Depression. J ECT. 2001;17:15–21.View ArticlePubMedGoogle Scholar
  39. Pritchard WS, Duke DW. Measuring “Chaos” in the Brain, A tutorial review of EEG dimension estimation. Brain Cognition. 1995;27:353–97.View ArticlePubMedGoogle Scholar
  40. Lopes-da-Silva F. Neural mechanism underlying brain wave:from neural branches to networks. Electro Clin Neurophysiol. 1991;79:81–93.View ArticleGoogle Scholar
  41. Jelles B, van Birgelen JH, Slaets JP, Hekster RE, Jonkman EJ, Stam CJ. Decrease of nonlinear structure in the EEG of Alzheimer patients compeared to healthy controls. Clin Neurophysiol. 1999;110:1159–67.View ArticlePubMedGoogle Scholar
  42. Wu DY, Dong WW. Nonlinear dynamic analysis in the EEG. Clin nerve Electrophysiol (Chin). 2003;12:335–8.Google Scholar
  43. Chen XL, Yao BL, Wei DN. EEG nonlinear analysis in mental arithmetic and directed. Chin J of Rehabilita Theory and Prac (Chin). 2005;11:978–80.Google Scholar
  44. Savit R, Li D, Zhou And W, Drury I. Understanding dynamic state changes in temporal lobe epilepsy. J Clin Neurophysiol. 2001;18:246–9.View ArticlePubMedGoogle Scholar
  45. Van L, Quyen M, Martinerie J, Navarro V, Baulac M, Varela FJ. Characterizing neurodynamic changes before seizures. J Clin Neurophysiol. 2001;18:191–208.View ArticleGoogle Scholar
  46. Chen XS, Wang HX, Zhang MD. Schizophrenia EEG. Nonlinear Dynamics. J Shanghai Jiaotong Uni (Medical Sciences) (Chin). 2006;26:169–71.Google Scholar
  47. Wan BK, Chen J, Ji HZ. Alzheimer’s EEG complexity and approximate entropy analysis. Beijing Biomed Eng (Chin). 2005;24:103–107,130.Google Scholar
  48. Schneider G, Sebel PS. Monitoring depth of anaesthesia. Eur J Anaesth. 1997;14:21–8.View ArticleGoogle Scholar
  49. Widman G, Schreiber T, Rehberg B, Hoeft A, Elger CE. Quantification of depth of anesthesia by nonlinear time series analysis of brain electrical activity. Phys Rev E. 2000;62:4898–903.View ArticleGoogle Scholar
  50. Wu DY, Jia BS, Yin L. Nonlinear EEG analysis in depth of anesthes ia monitoring. People’s Liberat Army Med (Chin). 2005;30:40–2.Google Scholar
  51. Wang YX, Wang XM, Liu H, Chen F. EEG nonlinear analysis in the efficacy evaluation of patients with acute carbon monoxide poisoning. J of Neurol (Chin). 2012;11:177–81.Google Scholar
  52. Stam CJ, van-Woerkom TC, Pritchard WS. Use of non-linear EEG measures to characterize EEG changes during mental activity. Electroencephalogr Clin Neurophysiol. 1996;99:214–24.View ArticlePubMedGoogle Scholar
  53. Guyer AE, Lau JY, McClure-Tone EB, Parrish J, Shiffrin ND, Reynolds RC, Chen G, Blair RJ, Leibenluft E, Fox NA, Ernst M, Pine DS, Nelson EE. Human Experimentation: code of ethics of the World Medical Association. Br Med J. 1964;2:177.View ArticleGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement